Sector Update: Health Care Stocks Advance in Afternoon Trading

MT NewswiresDec 19 02:49

KalVista Pharmaceuticals' Sebetralstat Poised to Disrupt Acute HAE Market With Oral Advantage, BofA Says

MT NewswiresDec 18 23:54

This Box Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

BenzingaDec 18 23:03

KalVista Wins New Buy at BofA on Potential of Lead Candidate

Seeking AlphaDec 18 22:52

BofA Securities Initiates KalVista Pharmaceuticals(KALV.US) With Buy Rating, Announces Target Price $22

Futu NewsDec 18 20:34 · Ratings

B of A Securities Initiates Coverage On KalVista Pharma With Buy Rating, Announces Price Target of $22

BenzingaDec 18 20:13 · Ratings